Richard Goschl

Title: Richard Goschl: Innovator in Antihypertensive Compounds

Introduction

Richard Goschl is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can inhibit the blood pressure-increasing action of the enzyme renin. His work has implications for the treatment of hypertension, a condition affecting millions worldwide.

Latest Patents

Richard Goschl holds a patent for "Novel 5-amino-4-hydroxyvaleryl derivatives." This patent describes compounds of a specific formula where various groups are defined, including R1, R2, R3, R4, R5, and R6, which represent different chemical structures. These compounds are designed to be used as antihypertensives, showcasing their potential to improve health outcomes for patients suffering from high blood pressure.

Career Highlights

Goschl has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work at the company has allowed him to focus on innovative solutions for health-related challenges, particularly in the area of cardiovascular health.

Collaborations

Throughout his career, Richard has collaborated with esteemed colleagues such as Peter Buhlmayer and Vittorio Rasetti. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Richard Goschl's contributions to the field of antihypertensive compounds highlight his role as an innovator in pharmaceuticals. His patent reflects a commitment to addressing critical health issues, and his collaborations further enhance the impact of his work.